Dr. Sharsti Sandall, PhDExecutive Director, ADC Biology at PfizerSpeaker
Agenda Sessions
Insights from a Decade of Clinical Experience with Vedotin ADCs: Target Selection, Tumor Type, and Combination Strategies
, 11:30amView Session